Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Casaubon who wrote (8649)	11/22/2004 6:00:25 PM
From: Stephen O	Read Replies (1) \| Respond to of 9523

I'm surprised at you Casaubon, it's a well written article and if anything leans to my way of thinking and you recommend it. I thought , according to you, that the drug companies are all very ethical and honest and altruistic. Apparently not. Here's some bits I C and P. Five years after the approval of any drug, "we don't know all of the harm," says Dr. James M. Wright, a professor of pharmacology at the University of British Columbia. "And there is always harm -- especially with potent drugs that have real benefits." and companies tend to bury data from trials that show safety problems, says Dr. Joseph Lau, a professor of medicine at Tufts University" and There's plenty of blame to go around. Vioxx' big benefit compared with older painkillers such as ibuprofen is that it causes fewer cases of stomach bleeding. But that's a problem for only a small percentage of patients. And thanks to an advertising blitz by Merck, its new drug became a best-seller, used by hundreds of thousands of people who didn't really benefit from its one advantage.